Online now: Modeling lung adenocarcinoma metastases using patient-derived organoids dlvr.it/TG2PFL

Our patient derived organoid paper in lung adenocarcinoma paper just out. First in vivo model to examine the biology of metastases. Congrats to all collaborators. ThoracicSurgeryMSK Memorial Sloan Kettering Cancer Center AATS Cell Reports Medicine

New paper in Clinical Cancer Research from Drs. Sam Rosner , Kristen A. Marrone, MD and Kellie N. Smith @hopkinsthoracic analyzing outcomes by KRAS + STK11 mutation status in pts treated with neoadjuvant IO for lung ca! #lcsm KRASKickers LUNGevity Foundation aacrjournals.org/clincancerres/…

Our ThoracicSurgeryMSK #lungscreening team in action! If you’re at the Memorial Sloan Kettering Cancer Center Koch clinic today, stop by for same-day screening with our all-star team!! #lcsm

A group of thoracic oncology experts at Memorial Sloan Kettering Cancer Center (MSK) wore white to bring awareness to lung cancer awareness month and support those living with lung cancer.

Not sure if #lungscreening is right for you? Here are six things you need to know from our team ThoracicSurgeryMSK Memorial Sloan Kettering Cancer Center ! #LungCancerAwareness #LungCancerAwarenessMonth #lcsm mskcc.org/news/six-myths…

Our six MSKCC superstar residents and fellows enjoying themselves at our holiday party!! We appreciate them and all they do for our patients!! ⁦Memorial Sloan Kettering Cancer Center⁩ ⁦Katherine Gray⁩ ⁦AATS⁩ ⁦Daniela⁩

Starting 2025 with the most awesome group of AATS staff who are the rockstars behind our Board & Foundation. Couldn’t be in a better place!! ⁦David R. Bobbitt⁩ ⁦Jones David R.⁩ ⁦AATS⁩

Reminder: A new TSOG-supported trial, TROPION-Lung12, is now available to be opened for accrual. If your site is interested in participating in the protocol, please email Kelly Travis at [email protected] or Maria Singh at [email protected].

We are excited to announce the #AATS2025 Guest Speaker is Alex Honnold—the only person to free solo Yosemite’s 3000 foot rock monolith, El Capitan. Hear his inspirational story in Seattle during the Plenary Session on May 3. Learn more about his feats: events.aats.org/am25/alex-honn…

DukeCTSurgery welcomes Professor Hiroshi Date to the Section of General Thoracic Surgery! Dr. Date is a world-renowned surgeon with expertise in Thoracic surgical oncology and lung transplantation. An honor and outstanding addition to our Duke Surgery team!

#GeneralThoracic #CME article from Benjamin Resio et al on Commission on Cancer Standards for Lymph Node Sampling and Oncologic Outcomes After Lung Resection: doi.org/10.1016/j.atho… #AnnalsCME Kay See Tan Smita Sihag Jones David R.

Researchers at Memorial Sloan Kettering Cancer Center found there are high-risk features associated with recurrence in stage I lung adenocarcinoma by analyzing 1912 patients with pathologic stage I LUAD who underwent R0 resection from 2010 to 2020. Log in to #JTCVS to read: doi.org/10.1016/j.jtcv…

Dr Jones David R. and a tremendous planning group composed of top surgeons in the speciality have built an amazing program. You must be there! #AATS2025 #Scholarship

Reminder: A new TSOG-supported trial, TROPION-Lung12, is now available to be opened for accrual. If your site is interested in participating in the protocol, please email Kelly Travis at [email protected] or Maria Singh at [email protected].

I just heard huge news that needs to be celebrated! Today marks 40 years of research and care for Dr Mark Kris Memorial Sloan Kettering Cancer Center Dr Kris has been a champion for innovative research, playing a pivotal role in many advancements over the past 4 decades. His contributions to science

New lung cancer research: Mediastinal lymph node dissection in segmentectomy for peripheral c-stage IA (≤2 cm) #NSCLC—how beneficial is it? Find out from surgeons in Tokyo by reading the study in #JTCVS: doi.org/10.1016/j.jtcv…

Deadline for AATS #ITSOS2025 abstracts tomorrow This is one of the best thoracic surgical oncology meetings of the year. Get your abstracts in! See you in Boston this September

I’m happy to share our latest work on tumour necrosis! During my time in the Mikala Egeblad lab, we found that tumour necrosis is not a passive phenomenon secondary to tumour growth, but an active phenomenon driven by neutrophils and NETs! Thread below: (1/13) nature.com/articles/s4158…

The AATS is proud to announce the #ITSOS2025 Giants and Master Surgeon Lectures. Don't miss Douglas E Wood, Malcolm M. DeCamp Jr., and Cameron D. Wright give talks dedicated to treating surgical thoracic oncology. Register today: events.aats.org/international-…